Search Results - mahin+maines

3 Results Sort By:
A Novel Approach to Treatment of Hyperglycemia Using a Nano-Particle-Encapsulated Peptide
A novel approach to treat Type 2 diabetes.Problem solved by this TechnologyThe highly inconvenient insulin injections remain the most prevalent treatment for Diabetes. By 2020, the global insulin market is expected to top $48 billion annually as insulin production costs are increasing and more insulin is being administered to diabetics due to developing...
Published: 7/21/2016   |   Inventor(s): Mahin Maines
Category(s): Therapeutic
Biliverdin Reductase (BVR) Peptides That Inhibit PCK-delta for the Potential Treatment of Cancer and Inflammation
Applications: Dr. M. Maines is a leading expert in BVR research and has uncovered many applications for this enzyme. In this invention she has linked BVR to modulation of PKC and found potent inhibitory peptides that may have utility in both understanding and treating cancer. A multiplicity of functions has been ascribed to PKC. Recurring themes...
Published: 7/22/2011   |   Inventor(s): Mahin Maines
Keywords(s): Cancer, Oncology, Peptide, Protein, Target Validation, Therapy
Category(s): Therapeutic
Human Biliverdin Reductase is a New Member of the Insulin Receptor Substrate Family with Serine/Threonine/Tyrosine Kinase Activity
Applications:Human biliverdin reductase (BVR) is an evolutionary conserved soluble enzyme that was originally characterized in the context of its reductase activity (conversion of biliverdin to bilirubin) and more recently shown to possess serine/threonine/tyrosine kinase activity. The present work demonstrates that this dual kinase activity of BVR...
Published: 6/17/2009   |   Inventor(s): Mahin Maines
Keywords(s): Cell Signalling, Therapy
Category(s): Therapeutic